Bio-Techne and Novomol-Dx announces development of Bio-Marker Pathfinder

Bio-Techne and Novomol-Dx, a molecular diagnostics company, announced the development of Bio-Marker Pathfinder, or BMP, a first of its kind ocular biomarker kit, as a point-of-care application. Novomol-Dx is a molecular diagnostics company focused on commercializing tests for the diagnosis and treatment of ophthalmic diseases utilizing biomarkers discovered over the last decade at Narayana Nethralaya Foundation, in association with Grow Laboratories & Narayana Nethralaya, a specialty eye care hospital chain in Bangalore India. The BMP kit runs on Bio-Techne’s Ella, a benchtop automated immunoassay platform leveraging Bio-Techne’s R&D Systems branded reagents to deliver accurate, reliable, and highly reproducible data in less than 90 minutes. Ella’s microfluidic-based cartridges with separate channels enable precision multiplexing in a hands-free system, making it ideal for diagnostic clinical use.